conventional procedure, while nursing intervention is limited to periodic lifting of the bag containing concentrated proteins. In our experience this technique requires only minimal training of junior doctors and nurses, and it can be safely performed without supervision after being carried out three or four times. Moreover, this part of the procedure can now be automated by using a new dedicated machine (Bellco, Mirandola, Italy).
The use of less expensive albumin substitutes has also been recently suggested. '7 18 Polygeline was recently shown to be a safe replacement for human albumin for re-expanding plasma volume in cirrhotic patients with refractory ascites.'8 However, the efficacy and safety of long term use of these compounds in patients with relapsing ascites is still unknown. Planas et al showed that dextran 70 significantly increased plasma renin activity and plasma aldosterone concentrations in patients who had total paracentesis.'7 Their data suggest that dextran 70 is less effective than albumin in protecting patients from a decrease in intravascular volume.
In conclusion, our study indicates that short term treatment with spontaneous ascites filtration and reinfusion is safe and effective and that it is less expensive than total paracentesis plus intravenous albumin infusion for treating tense ascites. Further studies aimed at comparing the efficacy and safety of long term treatment with spontaneous ascites filtration and reinfusion with total paracentesis plus albumin or polygeline infusion in cirrhotic patients with recurrent ascites are warranted.
We thank Dr M L Petroni for her advice and useful criticism in revising the paper as well as for continued support and encouragement. 64-9 in 1985) . The rise was seen in all spastic categories, including severely and multiply handicapped children.
Conclusions-Large increases in the use of interventions aimed at reducing birth asphyxia and handicaps had not (by 1985) resulted in lower rates of cerebral palsy. This suggests that birth asphyxia is not a major cause. The increased survival of low birthweight infants has resulted in more cerebral palsy in this group, due either to postnatal complications of immaturity or prenatal damage to the fetal brain. These findings have implications for planning perinatal care and for litigation for putative obstetric malpractice in cerebral palsy cases.
Introduction
As the proportions of stillbirths and neonatal deaths have fallen in most developed countries interest has increased in using the trends of occurrence of cerebral palsy as a measure of the benefits and hazards of obstetric (intrapartum) and neonatal care. Most countries record deaths as part of their vital registration, but few have population data on cerebral palsy, which require special collection.'
There is also concern about the increasing expensive litigation in the United States,2 United Kingdom,3 and now Australia45 for children born with cerebral palsy, which is adversely affecting the provision and practice of obstetrics. Lawsuits related to cerebral palsy are rising despite the fact that recent research suggests that most cerebral palsy syndromes are not a result of perinatal asphyxia and therefore could not have been prevented by better obstetric care.67 A recent article intimated that obstetricians had done themselves a disservice by promising that with interventions such as electronic fetal monitoring and caesarean sections most cases of cerebral palsy could be prevented and that few children would be born handicapped. 3 We present the most recent data on the trends in perinatal deaths and cerebral palsy in Western Australia. These trends are discussed in relation to current practices in perinatal care.
Subjects and methods
In Western Australia stillbirth is defined as the death before delivery of a fetus of at least 20 weeks' gestation or 400 g birth weight and neonatal death as the death of an infant after birth and up to 28 days of life. Low birth weight was less than 2500 g, very low birth weight less than 1500 g, and preterm birth a delivery before 37 weeks' gestation.
Cerebral palsy is a group of non-progressive disorders of movement and posture due to a defect or lesion of the developing brain. figure 2 show the numbers and proportions of stillbirths, neonatal deaths, and cases of cerebral palsy according to birth weight.
STILLBIRTHS
Stillbirth rates fell consistently with increasing birth weight to a constant rate of around 2/1000 total births for infants weighing 3000 g or more. Below this weight the rate in each birthweight group was significantly higher than that in the next highest group (p<O-Ol). The rates also fell significantly with time (p<0001), with an overall fall of about 15% from one period to the next (rate ratio 0 85, 95% confidence interval 0-80 to 0 90). There was no significant difference in the fall with time between birthweight groups (p=063), the greatest fall being in the groups 1000-1499 g and 2>4000 g.
NEONATAL DEATHS
The pattern for neonatal death rates was similar to that for stillbirths but with a more rapid fall with increasing birth weight and a slightly lower rate for those weighing more than 3000 g. The fall in rate with time was also greater than for stillbirths with a decrease of about 25% per period (rate ratio 0 74, 0-69 to 0-79).
CEREBRAL PALSY
The rates of cerebral palsy also fell with increase in birth weight to a roughly constant rate for weights over increase per period in both the <1000 g and 1000-1499 g groups (p<0 03) and a non-significant fall in higher birthweight groups. Diplegia-Over all years the highest rates were in infants weighing 1000-1499 g with steady falls as birth weight increased. There was a 17% fall per period in total diplegia rates (p=0 06). Although rates in low birthweight groups increased in each period, there was no significant trend (p-0-1). The steady fall in heavy diplegic infants across periods was not significant.
Quadriplegia-Over all weights there was a 22% increase per period (p=0-18) in rates of quadriplegia. In the <1000 g group there was a 70% increase and in the 1000-1499 g group a 150% increase (p<004) per period, with a non-significant fall in other groups.
When rates of cerebral palsy by birth weight were calculated per 1000 live births for each subtype similar patterns were observed except that the rise in spastic diplegia in infants <1500 g was significant (p<003).
The numbers of cases of ataxic, athetoid, or dystonic cerebral palsy were small and showed no real trend over time, although dyskinetic cerebral palsy rates seemed to have risen in recent years, mainly in infants born at term.
Discussion
We have presented unique population data on perinatal mortality and cerebral palsy over a period during which obstetric and neonatal care has changed dramatically. Several interesting patterns were observed, some of which were unexpected.
Most developed countries have shown improved perinatal mortality rates similar to those reported here for Western Australia. These improvements have been associated with more widespread use of obstetric and neonatal interventions aimed at detecting and reducing intrapartum morbidity, particularly from intrapartum asphyxia, and treating the complications of extreme immaturity. Changes in the population distribution of maternal demographic and biological characteristics such as falling extremes of parity and age, improved height, and decreases in other risk factors also may have contributed to better perinatal outcomes.
Rates of cerebral palsy remained steady throughout the study period. This is consistent with recent data which indicate that the proportion of cases of cerebral palsy which are due to birth asphyxia, or which could be avoided by perinatal care, is much less than previously thought. 15-'7 These findings are most important in relation to litigation as well as to the possible causes and prevention of cerebral palsy. Obstetricians should heed recent advice that they are "shooting themselves in the foot" if they continue to promise a perfect baby in the face of a constant cerebral palsy rate of 2-2 5 per 1000. 3 The rise in cerebral palsy in low birthweight infants mirrors falls in perinatal mortality and particularly neonatal mortality in such infants. But There are several possible explanations of the rise in cerebral palsy in low birthweight infants. One theory is that as more low birthweight infants survive they suffer the complications of extreme immaturity such as periventricular leucomalacia, intraventricular haemorrhage, respiratory distress, and sepsis, resulting in postnatal brain damage in otherwise normal infants. 23 24 This hypothesis has important implications for neonatal intensive care.
Another hypothesis is that cerebral palsy and preterm birth have similar origins in pregnancy and that more of these children, who were compromised well before birth, are now surviving in increasing numbers.'9 This has implications for further research into the aetiology and future prevention of the cerebral palsies and preterm birth. Another Australian study of cerebral palsy in very low birthweight infants could not identify any obvious preventable factors25; though many of the infants with cerebral palsy had perinatal risk factors, they were also present in low birthweight children without cerebral palsy. Other data from the United Kingdom23 and United States626 support this finding. There are certainly reports now of white matter necrosis having been present well before birth in low birthweight infants dying in the neonatal period.2729
The rise in cerebral palsy in preterm infants was not mainly in spastic diplegia, which might be expected if the first hypothesis accounted for most of the increase. Early studies of low birthweight infants who subsequently were noted to have cerebral palsy reported that most had spastic diplegia, which was often mild and associated with minimal other handicap. In particular, they tended to be of normal intelligence.3032 In more recent studies the rise in occurrence of cerebral palsies in low birthweight infants seems to be in all spastic syndromes and associated with other handicaps, many of which are classified as severe." 8 19 
Introduction
Aneurysmal subarachnoid haemorrhage is a serious disease with high mortality and morbidity. Delayed cerebral ischaemia and rebleeding are the most important causes of death and disability, after the primary bleed.'3 The risk of delayed ischaemia is best predicted by the amount of subarachnoid4 and intraventricular5 blood, as well as by previous hypertension,6 irrespective of clinical condition on admission or hydrocephalus. There are no uniformly accepted predictive risk factors for rebleeding except the administration of antifibrinolytic drugs, which reduce this risk.4'5 The overall outcome can best be predicted by the initial clinical condition and the amount of subarachnoid blood as a poor initial condition is associated with mortality due to the primary bleed. 4 Besides these independent risk factors, which are associated with the severity of haemorrhage, there may also be pre-ictal factors other than hypertension that can impair the outcome. It is not known whether alcohol consumption, smoking, or the use of nonsteroidal anti-inflammatory drugs influence outcome. Alcohol consumption, especially heavy drinking, has been shown to increase the risk of all types of stroke,7 while smoking increases the risk of subarachnoid haemorrhage'2"5 and cerebral infarction.'°1 ' '5 Use of non-steroidal anti-inflammatory drugs seems to increase the risk of haemorrhagic stroke. 16 Hence, these factors might also impair outcome after subarachnoid haemorrhage by making patients prone to cerebral ischaemia, rebleeding, or a severe initial bleed. Awareness of factors worsening the outcome could be important in the management of subarachnoid haemorrhage. This prospective study investigated the influence of these factors on the outcome after subarachnoid haemorrhage.
Patients and methods
From January 1985 to September 1986 a total of 291 patients with aneurysmal subarachnoid haemorrhage were admitted to the Helsinki University Hospital. After they had been admitted, I interviewed patients, their family members, and fellow workers, as appropriate, about smoking and alcohol habits, use of medicines, and previous diseases of the patient. Data were obtained solely from the patients themselves in 42 cases and from family members only in 55 cases or fellow workers only in six cases when the patient was in poor condition. In the remaining 188 cases information was obtained from both patients and family members. In about a quarter of these cases either the patient or the family member underestimated or overestimated alcohol intake. Because underestimation is more likely in alcohol intake, the greater amounts reported in these cases were registered.
Alcohol consumption, both recent and long term, was calculated from the amount of alcohol consumed before haemorrhage. Patients with two or more positive answers to the four questions in the CAGE interview were considered to be "CAGE positive," a classification that correlates well with heavy drinking.'7 18 On admission, blood samples were obtained for measurement of markers of alcohol intake (erythrocyte mean cell volume, y-glutamyltransferase concentration, and platelet count). Cigarette smoking was categorised as never smoked, former smoker, and current smoker-,<10, 11-20 >20 cigarettes a day, respectively. Use 
